Welcome to our dedicated page for MODERN MOBILITY AIDS news (Ticker: MDRM), a resource for investors and traders seeking the latest updates and insights on MODERN MOBILITY AIDS stock.
Modern Mobility Aids Inc. (MDRM) is a company focused on revolutionizing healthcare through telehealth initiatives. They are expanding their Galileo Life Sciences business in Ontario, Canada's telehealth service market, offering services like primary care, specialty care, and easy care. With positive patient feedback and a planned geographic expansion, MDRM aims to provide high-quality healthcare solutions to a wider audience. By enhancing their technological infrastructure and forming strategic partnerships, MDRM is committed to driving innovation in the growing telehealth market.
Modern Mobility Aids, Inc. (OTC: MDRM) provided its annual shareholder letter, highlighting significant developments over the past year. The company successfully launched virtual-care clinics in Ontario and is expanding its services, including annual truck driver physicals. A key achievement is the near-completion of the acquisition of 2542153 Ontario Ltd, which generates over a million dollars in revenue. Plans to expand into West Africa and the development of a custom telehealth platform with Digital-Care are also noted. The company aims for revenue growth and full OTC market reporting in Q1 2023.
Galileo Life Sciences Inc. (OTC: MDRM) has announced the commencement of revenue generation and plans for expansion. Operating in Ontario, the company aims to enhance healthcare accessibility through its telehealth platform, providing virtual consultations at pharmacies. Currently, three clinics serve the Toronto area, with a target of 25 by year-end 2022. An agreement with 2542153 Ontario Inc. facilitates access to licensed virtual care physicians. CEO Tito DiMarco emphasizes the company's commitment to growth and profitability, leveraging advanced technology for quality patient care.
Galileo Life Sciences Inc (OTC: MDRM), also known as Modern Mobility Aids, is set to open its first telehealth clinic, "Virtual-Care-Plus" (VCPlus), on October 17, 2021, in Brampton, Ontario. By the end of October, two more VCPlus clinics will open in Markham and North York. The company has enlisted licensed primary care physicians to provide virtual consultations, utilizing secure technology from AMD Global Telemedicine. The global telehealth market is projected to grow from $90 billion in 2021 to $636 billion by 2028, signifying a robust opportunity for Galileo's innovative services.
Galileo Life Sciences has positioned itself at the forefront of the telehealth industry by offering robust solutions that integrate advanced technology for real-time patient monitoring. The company aims to expand globally with virtual clinics, particularly in regions like India, Pakistan, and Colombia. The global telemedicine market is projected to reach USD 298.9 billion by 2028, with a CAGR of 22.4%. This growth is driven by rising chronic illnesses and the need for cost-effective healthcare solutions.
FAQ
What is the current stock price of MODERN MOBILITY AIDS (MDRM)?
What is the market cap of MODERN MOBILITY AIDS (MDRM)?
What is Modern Mobility Aids Inc. (MDRM) focused on?
What services does MDRM offer in the telehealth market?
What feedback has MDRM received from patients regarding their telehealth services?
What are MDRM's plans for geographic expansion?
How is MDRM enhancing their technological infrastructure?
What is MDRM's commitment to driving innovation in the telehealth market?
What is the estimated market size for telehealth by 2028?
What is MDRM's goal with their impact investment?
How can I contact Modern Mobility Aids Inc.?
Where can I find more information about Modern Mobility Aids Inc.?
